Bellevue Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.82M | Sell |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $75.5M | Buy |
|
|||||
|
2024
Q2 | $31.9M | Buy |
|
|||||
|
2024
Q1 | $48.6M | Sell |
|
|||||
|
2023
Q4 | $78.5M | Sell |
|
|||||
|
2023
Q3 | $100M | Buy |
|
|||||
|
2023
Q2 | $104M | Buy |
|
|||||
|
2023
Q1 | $71.1M | Buy |
|
|||||
|
2022
Q4 | $55.7M | Buy |
|
|||||
|
2022
Q3 | $67.2M | Sell |
|
|||||
|
2022
Q2 | $62M | Sell |
|
|||||
|
2022
Q1 | $84.4M | Buy |
|
|||||
|
2021
Q4 | $72.2M | Sell |
|
|||||
|
2021
Q3 | $94M | Sell |
|
|||||
|
2021
Q2 | $76.8M | Buy |
|
|||||
|
2021
Q1 | $71.3M | Buy |
|
|||||
|
2020
Q4 | $50.5M | Sell |
|
|||||
|
2020
Q3 | $40.6M | Sell |
|
|||||
|
2020
Q2 | $35.8M | Buy |
|
|||||
|
2020
Q1 | $24.9M | Buy |
|
|||||
|
2019
Q4 | $32.1M | Buy |
|
|||||
|
2019
Q3 | $21.8M | Buy |
|
|||||
|
2019
Q2 | $18.7M | Buy |
|
|||||
|
2019
Q1 | $17.7M | Buy |
|
|||||
|
2018
Q4 | $903K | Buy |
|